H. Hartvig

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial

R. Cuddihy, S. Filetti, M. Davies, 2011, International journal of clinical practice.

Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long‐acting insulin in Type 2 diabetes1

J. Christiansen, E. Vestergaard, T. Parkner, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel

C. Kapitza, A. Flint, L. Nosek, 2015, Journal of clinical pharmacology.

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

A. Astrup, S. Rössner, L. V. Van Gaal, 2013, International Journal of Obesity.

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial

R. Cuddihy, S. Filetti, R. Pratley, 2011, International journal of clinical practice.